Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice
Authors:
- 21 July 2015
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 15 (19) , 3349-3355
Abstract
Alzheimer's disease (AD) is a neurodegenerative disease displaying extracellular plaques formed by the neurotoxic amyloid β‐peptide (Aβ), and intracellular neurofibrillary tangles consisting of protein tau. However, how these pathologies relate to the massive neuronal death that occurs in AD brains remain elusive. Neprilysin is the major Aβ‐degrading enzyme and a lack thereof increases Aβ levels in the brain twofold. To identify altered protein expression levels induced by increased Aβ levels, we performed a proteomic analysis of the brain of the AD mouse model APPsw and compared it to that of APPsw mice lacking neprilysin. To this end we established an LC‐MS/MS method to analyze brain homogenate, using an 18O‐labeled internal standard to accurately quantify the protein levels. To distinguish between alterations in protein levels caused by increased Aβ levels and those induced by neprilysin deficiency independently of Aβ, the brain proteome of neprilysin deficient APPsw mice was also compared to that of neprilysin deficient mice. By this approach we identified approximately 600 proteins and the levels of 300 of these were quantified. Pathway analysis showed that many of the proteins with altered expression were involved in neurological disorders, and that tau, presenilin and APP were key regulators in the identified networks. The data have been deposited to the ProteomeXchange Consortium with identifiers PXD000968 and PXD001786 (http://proteomecentral.proteomexchange.org/dataset/PXD000968 and (http://proteomecentral.proteomexchange.org/dataset/PXD001786). Interestingly, the levels of several proteins, including some not previously reported to be linked to AD, were associated with increased Aβ levels.Keywords
Funding Information
- Alzheimerfonden and the Swedish Research Council, Sweden
- RIKEN Brain Science Institute, Japan
- Ministry of Education, Sports, Science and Technology, Japan
- Ministry of Health, Labour and Welfare, Japan
This publication has 20 references indexed in Scilit:
- ProteomeXchange provides globally coordinated proteomics data submission and disseminationNature Biotechnology, 2014
- Potent amyloidogenicity and pathogenicity of Aβ43Nature Neuroscience, 2011
- Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's diseaseBrain Research, 2010
- A Serial Analysis of Gene Expression Profile of the Alzheimer’s Disease Tg2576 Mouse ModelNeurotoxicity Research, 2009
- Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillationBrain, 2009
- Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during agingProceedings of the National Academy of Sciences, 2006
- Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive FunctionJournal of Biological Chemistry, 2006
- Metabolism of amyloid-β peptide and Alzheimer's diseasePharmacology & Therapeutics, 2005
- Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological depositionNature Medicine, 2000
- Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathologyProceedings of the National Academy of Sciences, 1997